These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6150138)

  • 1. [Use of vasodilator agents in the treatment of cardiac insufficiency].
    Ruano Calvo FJ; Larman Tellechea M; Pajarón López A
    Med Clin (Barc); 1984 Oct; 83(11):460-8. PubMed ID: 6150138
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vasodilator therapy in cardiac failure].
    Akatsuka N
    Nihon Rinsho; 1993 May; 51(5):1276-80. PubMed ID: 8101237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of vasodilator agents in the therapy of chronic cardiac insufficiency].
    Koller H; Prager H
    Wien Med Wochenschr; 1982 Oct; 132(19):465-70. PubMed ID: 6129750
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vasodilator treatment of chronic heart failure].
    Woroszylska M
    Kardiol Pol; 1983; 26(10):741-51. PubMed ID: 6141316
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasodilators in heart failure. Basis for their use].
    Mesquita ET; Mady C
    Arq Bras Cardiol; 1994 Dec; 63(6):531-6. PubMed ID: 7605242
    [No Abstract]   [Full Text] [Related]  

  • 7. Compensatory changes of sympathetic tone, the renin-angiotensin-aldosterone system, vasopressin, and ANF as potential therapeutic targets in congestive heart failure.
    van Zwieten PA
    Z Kardiol; 1988; 77 Suppl 5():67-76. PubMed ID: 2975894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diastolic cardiac insufficiency].
    Spoto S; Palma Modoni A; De Galasso L
    Clin Ter; 2002; 153(5):355-7. PubMed ID: 12510423
    [No Abstract]   [Full Text] [Related]  

  • 9. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic nervous system in heart failure.
    Cohn JN
    Circulation; 2002 Nov; 106(19):2417-8. PubMed ID: 12417535
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
    Pimenta J; Pereira M; Castro A; Dias P; Azevedo A; Bettencourt P; Ferreira A
    Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohumoral mechanisms in heart failure: role in pathogenesis, therapy, and drug tolerance.
    Dzau VJ; Hollenberg NK; Williams GH
    Fed Proc; 1983 Dec; 42(15):3162-9. PubMed ID: 6357858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congestive heart failure. Pathophysiology and treatment. Part Three.
    Panetta F
    Aust Fam Physician; 1987 Mar; 16(3):327, 331-2. PubMed ID: 3038064
    [No Abstract]   [Full Text] [Related]  

  • 14. [Renal sequelae of sympathetic hyperactivity].
    Watschinger B; Habicht A
    Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic cardiac insufficiency in 1983].
    Turini GA
    Schweiz Med Wochenschr; 1983 Jul; 113(26):951-6. PubMed ID: 6612276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vasodilators in the treatment of arterial hypertension].
    Gherasim L; Dorobanţu M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(4):289-302. PubMed ID: 6150533
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of hypertensive heart disease: vasodilator agents in the forefront].
    Bolli P; Bühler FR
    Ther Umsch; 1984 Feb; 41(2):150-5. PubMed ID: 6200947
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neurohormonal factors in heart failure. II].
    Cosín Aguilar J; Cruz Fernández JM; de Teresa Galván E; Ferreira Montero IJ; López-Sendón J; Soler Soler J; Tamargo Menéndez J
    Rev Esp Cardiol; 1996 May; 49(5):317-27. PubMed ID: 8744385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sublingual captopril: indications and advantages?].
    Meyer GJ
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S4. PubMed ID: 10818992
    [No Abstract]   [Full Text] [Related]  

  • 20. Congestive heart failure.
    Dreiling RJ; Dunn M
    Compr Ther; 1984 Sep; 10(9):54-9. PubMed ID: 6488752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.